Increased secretion of CXCL12 has been associated with tumor chemorepellent activity towards antigen-specific T cells and with escape from immune control in melanoma and in pancreatic ductal adenocarcinoma (PDA) murine models [209,210]. The gene discussed is CXCL12; the disease is Patent ductus arteriosus.